The PARADIGM study

Premixed insulin (75% insulin lispro protamine suspension,  25% insulin lispro) is non-inferior to glargine+lispro. The PARADIGM study  Patients with type 2 diabetes (T2D) can fail to achieve optimal glycaemic control despite  diet, exercise and oral anti-hyperglycaemic agents, however, long-term glycaemic control  on insulin therapy reduces the risk of both micro and Read more…